Study Finds Link Between Moderate Level Coffee or Caffeine Intake and Risk Of Multiple Cardiometabolic DiseasesConsuming ...

The median phenobarbital dosage used by people with epilepsy was 60 mg (range ... and Alzheimer's disease taking levetiracetam (n=38), phenobarbital (n=28) and lamotrigine (n=29), and a control group ...

A UCL study found that lamotrigine is as effective as mexiletine for treating non-dystrophic myotonia, a rare muscle disorder ...

Lamotrigine, a drug commonly used to treat epilepsy and certain mood disorders, has been shown to be an excellent treatment option for a rare genetic neuromuscular disease known as non-dystrophic ...

The study, published in Lancet Neurology, detailed the "head-to-head" trial implemented by the researchers to test two drugs, ...

for its Abbreviated New Drug Application (ANDA) Lamotrigine Extended-Release Tablets USP, 200 mg, 250 mg, and 300 mg. The approved ANDA is therapeutically equivalent to the reference listed drug ...

This latest research on non-dystrophic myotonia offers promising results for those affected by the condition. Published in ...

The study, published in Lancet Neurology, detailed the "head-to-head" trial implemented by the researchers to test two drugs, ...

for its Abbreviated New Drug Application (ANDA) for Lamotrigine Extended-Release Tablets USP in 200 mg, 250 mg, and 300 mg strengths. These tablets are the therapeutic equivalent to GlaxoSmithKline’s ...

granted final approval for its Abbreviated New Drug Application (ANDA) for Lamotrigine Extended-Release Tablets USP in 200 mg, 250 mg, and 300 mg strengths. These tablets are the therapeutic ...

for its Abbreviated New Drug Application (ANDA) Lamotrigine Extended-Release Tablets USP, 200 mg, 250 mg, and 300 mg. The approved ANDA is therapeutically equivalent to the reference listed drug ...